Document is current
Any future updates will be listed below
-
Authors
Storck, Anthea
Beutel, Gernot
Kochanek, Matthias
Schellongowski, Peter
Staudinger, Thomas
Buchtele, Nina
Cserna, Julia
Brueder, Nicole
Lueck, Catherina
Liebregts, Tobias
Tzalavras, Asterios
Hammersen, Jakob
Kroschinsky, Frank
Forkert, Randolf
Kiehl, Michael G.
von Bergwelt-Baildon, Michael
Grans-Sibel, Judit
Bach, Franziska
Borrega, Jorge Garcia
Naendrup, Jan-Hendrik
Shimabukuro-Vornhagen, Alexander
Eichenauer, Dennis A.
Böll, Boris
,
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 29 April 2025
First Online: 10 May 2025
Declarations
:
: This study was performed in accordance with the principles of the Declaration of Helsinki and approved by the Institutional Review of the Medical Faculty and the University Hospital Cologne on December 18, 2013 (#13–380). All participating providers from the iCHOP registry obtained institutional review board approval from their institutions in accordance with local ethics regulations.
: Not applicable.
: P.S. has received honoraria from Abbvie, Astro Pharma, Gilead, Jazz Pharmaceuticals, Novartis, Pfizer, and Roche; his University has received research funding from Amgen, Astellas, Astro Pharma, and Baxter; as well as competitive research grants from the Initiative Krebsforschung, the European Society of Intensive Care Medicine, and the European Commission. C.L. has received honoraria from Gilead. A.T. is an advisor for and reports receiving travel support from Kite/Gilead. J.G.B. has received research funding and travel support from Kite/Gilead. D.A.E. has received honoraria from Sanofi-Genzyme and Takeda. B.B. has received honoraria and research funding from Amgen, Gilead, MSD, Miltenyi, Noscendo, Novartis, Pfizer and Takeda. The remaining authors have no financial or non-financial interests to disclose.
